ArticlePharmaceutical research2024

Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy.

Umar-Farouk Mamani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.